| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | ALKS Alkermes Plc | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.40 | $300,559.50 | -10.0% | - | - | |
| May 1, 2026 | ANIK Anika Therapeutics, Inc. | Henneman John B III | Director | Buy | 5,000 | $14.66 | $73,319.50 | +10.0% | - | - | |
| Apr 30, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 30,000 | $0.15 | $4,635.00 | -0.6% | - | - | |
| Apr 30, 2026 | ANIK Anika Therapeutics, Inc. | Griffin Stephen D. | President And CEO | Buy | 12,200 | $12.29 | $149,880.66 | +50.9% | - | - | |
| Apr 30, 2026 | PAHC Phibro Animal Health Corporation | Bendheim Jack49 | President And CEO | Sell | 21,120 | $53.86 | $1,137,592.76 | -3.5% | - | - | |
| Apr 27, 2026 | UTHR United Therapeutics Corporation | Edgemond James45 | CFO And Treasurer | Sell | 10,000 | $568.83 | $5,688,318.95 | -5.8% | - | - | |
| Apr 23, 2026 | PCRX Pacira Biosciences, Inc. | Cross Shawn58 | Chief Financial Officer | Sell | 12,941 | $25.16 | $325,595.56 | -10.9% | - | - | |
| Apr 23, 2026 | PAHC Phibro Animal Health Corporation | Bendheim Jack49 | President And CEO | Sell | 21,120 | $54.79 | $1,157,091.24 | -3.9% | - | - | |
| Apr 22, 2026 | PCRX Pacira Biosciences, Inc. | Cross Shawn58 | Chief Financial Officer | Sell | 12,059 | $25.09 | $302,598.41 | -3.7% | - | - | |
| Apr 21, 2026 | TLRY Tilray Brands, Inc. | Hopkinson David G.52 | Director | Sell | 33,556 | $6.94 | $232,878.64 | -100% | - | - | |
| Apr 20, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $577.83 | $5,489,423.82 | -1.5% | - | - | |
| Apr 20, 2026 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 9,463 | $30.00 | $283,890.00 | -3.1% | - | - | |
| Apr 20, 2026 | UTHR United Therapeutics Corporation | Edgemond James45 | CFO And Treasurer | Sell | 10,000 | $577.86 | $5,778,606.91 | -3.3% | - | - | |
| Apr 20, 2026 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 19,645 | $29.96 | $588,615.28 | -7.0% | - | - | |
| Apr 20, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 32,500 | $0.15 | $4,904.50 | -0.3% | - | - | |
| Apr 20, 2026 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 32,500 | $0.15 | $4,904.50 | -0.3% | - | - | |
| Apr 9, 2026 | LQDA Liquidia Corporation | Kaseta Michael58 | CFO And COO | Sell | 133,789 | $40.24 | $5,383,388.40 | -24.5% | - | - | |
| Apr 9, 2026 | LQDA Liquidia Corporation | Jeffs Roger67 | Chief Executive Officer | Sell | 25,000 | $40.12 | $1,002,887.50 | -1.6% | - | - | |
| Apr 6, 2026 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 3,975 | $19.98 | $79,408.58 | -1.2% | - | - | |
| Mar 31, 2026 | PAHC Phibro Animal Health Corporation | Bendheim Jack49 | President And CEO | Sell | 14,080 | $53.75 | $756,833.70 | -7.7% | - | - | |
| Mar 27, 2026 | LQDA Liquidia Corporation | Bloch Stephen M | Director | Sell | 70,234 | $36.08 | $2,533,765.62 | -0.8% | - | - | |
| Mar 26, 2026 | PAHC Phibro Animal Health Corporation | Bendheim Jack49 | President And CEO | Sell | 21,120 | $55.21 | $1,166,104.50 | -4.8% | - | - | |
| Mar 20, 2026 | EOLS Evolus, Inc. | Avelar Rui67 | See Remarks | Sell | 3,119 | $4.75 | $14,815.25 | -0.7% | - | - | |
| Mar 20, 2026 | EOLS Evolus, Inc. | Moatazedi David67 | See Remarks | Sell | 13,669 | $4.75 | $64,929.12 | -2.2% | - | - | |
| Mar 18, 2026 | COLL Collegium Pharmaceutical, Inc. | Dieter David | EVP &General Counsel | Sell | 13,976 | $34.92 | $488,099.22 | -15.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.